Page last updated: 2024-08-24

triciribine and cyclin d1

triciribine has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Fazio, P; Gloesenkamp, CR; Hoffmann, B; Höpfner, M; Nitzsche, B; Ocker, M; Quint, K; Scherübl, H1

Other Studies

1 other study(ies) available for triciribine and cyclin d1

ArticleYear
AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors.
    International journal of oncology, 2012, Volume: 40, Issue:3

    Topics: Aging; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Gastrointestinal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Insulinoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Ribonucleosides; Signal Transduction

2012